유럽의 단백질 시퀀싱 시장 : 용도별, 최종 사용자별, 국가별 - 분석과 예측(2024-2033년)

Introduction to Europe Protein Sequencing Market

The Europe protein sequencing market is projected to reach $685.6 million by 2033 from $477.2 million in 2024, growing at a CAGR of 4.11% during the forecast period 2024-2033. Protein sequencing is the process of determining the precise order of amino acids in a protein, essential for understanding its structure, function, and role in biological systems. It plays a crucial role in biotechnology, biomedical research, drug discovery, and disease diagnostics, significantly contributing to advancements in precision medicine and targeted therapies. Protein sequencing provides valuable insights into post-translational modifications, protein interactions, and disease mechanisms, supporting breakthroughs in life sciences and healthcare.

In Europe, the adoption of protein sequencing is accelerating, driven by growing investments in proteomics research, the expansion of the biopharmaceutical industry, and increasing demand for personalized medicine. The two primary sequencing techniques are Edman degradation, which is effective for smaller proteins, and mass spectrometry, widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. The market comprises instruments, reagents, and consumables that facilitate sequencing processes, alongside contract research organizations providing specialized sequencing services.

Rising demand for biomarker discovery, drug development, and disease diagnostics is driving continuous innovation in protein sequencing technologies. With strong government support, increasing private-sector investments, and a robust research ecosystem, Europe is poised for significant growth in proteomics and protein-based research.

Market Introduction

The Europe protein sequencing market is experiencing steady growth, driven by increasing investments in proteomics research, expanding biopharmaceutical industries, and the rising demand for personalized medicine. Protein sequencing, which determines the precise order of amino acids in a protein, is essential for understanding protein structures, functions, and interactions. It plays a crucial role in drug discovery, disease diagnostics, and biomarker identification, supporting advancements in precision medicine and targeted therapies.

The market is primarily driven by advancements in sequencing technologies such as mass spectrometry and Edman degradation. Mass spectrometry is widely used for high-throughput proteomics due to its ability to analyze complex protein samples efficiently, while Edman degradation remains relevant for sequencing smaller proteins. Europe's strong focus on innovation, supported by government funding and collaborations between research institutions, pharmaceutical companies, and biotechnology firms, is fostering further developments in this field.

Key factors propelling market growth include increasing applications in oncology, neurodegenerative diseases, and infectious disease research. Additionally, the rising adoption of artificial intelligence and machine learning in proteomics is enhancing data analysis capabilities. With a well-established research ecosystem and growing investments in life sciences, the European protein sequencing market is poised for long-term expansion, shaping the future of proteomics and biomedical research.

Market Segmentation:

Segmentation 1: By Application

• Biotherapeutics
• Genetic Engineering
• Others

Segmentation 2: By End User

• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies

Segmentation 3: By Region

• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Selvita
• Merck KGaA
• Proteome Factory AG

Table of Contents

Executive Summary

Scope and Definition

1 Europe Protein Sequencing Market: Overview

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Product Launches in the Market
  • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
  • 1.1.3 High Demand for Biologics Development
• 1.2 Workflow of Protein Sequencing
  • 1.2.1 Protein Sequencing Workflow Overview
• 1.3 Regulatory Framework
  • 1.3.1 European Union (EU)
    • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.1.1.1 EU Medical Device Regulation
      • 1.3.1.1.2 EU In Vitro Diagnostic Regulation
    • 1.3.1.2 Regulatory Requirements for Clinical Protein Sequencing

Labs in the EU 26

• 1.4 Patent Analysis
  • 1.4.1 Patent Filing Trend (by Country)
  • 1.4.2 Patent Filing Trend (by Year)
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Europe Protein Engineering Market
    • 1.5.1.2 Expanding Applications in Research
    • 1.5.1.3 Technological Advancements in Protein Sequencing
  • 1.5.2 Market Restraints
    • 1.5.2.1 Shortage of Skilled Labour
    • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Protein Sequencing Market (By Region), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Germany
  • 2.2.5 U.K.
  • 2.2.6 France
  • 2.2.7 Italy
  • 2.2.8 Spain
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Landscape

• 3.1 Europe Protein Sequencing Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2021-September 2024
  • 3.1.2 Partnerships, Alliances, and Business Expansions
• 3.2 Company Profiles
  • 3.2.1 Merck KGaA
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Proteome Factory AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Services Offered
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 Selvita S.A.
    • 3.2.3.1 Overview
    • 3.2.3.2 Services Offered
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End Users
    • 3.2.3.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast